Trial intelligence / Profile preview

Immune Responses in Blood, Mucosa, and Skin After Influenza and Smallpox Vaccination

jRCT1030260284Recruiting

Start
Jul 2026
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Open-label trial of influenza vaccine in influenza and mpox (2 cohorts), sponsored by None. Primary endpoint: Pathogen-specific antibody titers. Started Jul 2026; status: recruiting.

02

Drugs

influenza vaccine
03

Conditions

influenzampox

Beyond the preview

Go deeper on jRCT1030260284.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1030260284.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call